| |
| |
|
| Insider
Information: |
Arkin Moshe |
| Relationship: |
10% Owner |
| City: |
Allegan |
| State: |
MI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
18,000,942 |
|
|
Indirect Shares
|
7,029,901 |
|
|
| Direct
Value |
$30,736 |
|
|
|
Indirect Value
|
$135,544,862 |
|
|
| Total
Shares |
25,030,843 |
|
|
| Total
Value |
$135,575,598 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Perrigo Co |
PRGO |
Director |
2011-08-31 |
1,130 |
2011-08-31 |
4,983,267 |
Premium* |
|
|
Ophthalmic Imaging Systems |
OISI |
Director, 10% Owner |
2010-05-26 |
13,338,603 |
|
0 |
Premium* |
|
|
Neurogesx Inc |
NGSX |
also member of 10% own... |
2010-09-09 |
2,648,107 |
2010-09-09 |
0 |
Premium* |
|
|
Keros Therapeutics, Inc. |
KROS |
10% Owner |
2020-04-13 |
2,013,102 |
2020-04-13 |
0 |
Premium* |
|
|
Werewolf Therapeutics, Inc. |
HOWL |
10% Owner |
2021-05-04 |
0 |
2021-05-04 |
2,046,634 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRGO |
Perrigo Co |
Vice Chairman |
• • • |
2005-03-17 |
4 |
A |
$0.00 |
$0 |
I/I |
10,022,092 |
10,022,092 |
|
- |
|
| OISI |
Ophthalmic Imaging System... |
Director |
– • • |
2010-05-26 |
4 |
B |
$0.00 |
$0 |
D/D |
3,581,089 |
13,338,603 |
3.84 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
10% Owner |
– – • |
2020-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,893,102 |
1,893,102 |
0 |
- |
|
| HOWL |
Werewolf Therapeutics, In... |
10% Owner |
– – • |
2021-05-04 |
4 |
A |
$0.00 |
$0 |
I/I |
1,646,634 |
1,646,634 |
0 |
- |
|
| HOWL |
Werewolf Therapeutics, In... |
10% Owner |
– – • |
2021-05-04 |
4 |
B |
$16.00 |
$6,400,000 |
I/I |
400,000 |
2,046,634 |
1.5 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2009-10-01 |
4 |
AS |
$34.13 |
$8,015,762 |
I/I |
(234,890) |
6,750,340 |
0 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2008-10-14 |
4 |
AS |
$35.10 |
$8,084,891 |
I/I |
(230,000) |
7,766,267 |
0 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2008-10-13 |
4 |
AS |
$34.34 |
$7,555,724 |
I/I |
(220,000) |
7,996,267 |
0 |
- |
|
| PRGO |
Perrigo Co |
Vice Chairman |
• • • |
2008-02-25 |
4 |
S |
$35.20 |
$7,270,316 |
I/I |
(206,039) |
9,674,803 |
0 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2011-02-16 |
4 |
S |
$74.68 |
$14,957,900 |
I/I |
(200,000) |
6,521,224 |
0 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2011-02-18 |
4 |
S |
$75.69 |
$15,138,420 |
I/I |
(200,000) |
6,321,224 |
0 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2011-08-30 |
4 |
S |
$96.46 |
$16,411,795 |
I/I |
(170,145) |
5,063,122 |
0 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2011-05-05 |
4 |
S |
$86.03 |
$14,199,582 |
I/I |
(165,050) |
5,856,174 |
0 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2008-11-03 |
4 |
AS |
$34.53 |
$5,528,973 |
I/I |
(160,100) |
7,407,066 |
0 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2008-11-28 |
4 |
AS |
$34.35 |
$5,495,984 |
I/I |
(160,000) |
7,021,966 |
0 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2011-05-18 |
4 |
S |
$86.31 |
$12,325,885 |
I/I |
(142,805) |
5,271,224 |
0 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2011-05-09 |
4 |
S |
$87.63 |
$12,366,564 |
I/I |
(141,127) |
5,649,952 |
0 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2008-10-31 |
4 |
AS |
$34.25 |
$4,640,956 |
I/I |
(135,500) |
7,567,166 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
10% Owner |
– – • |
2020-04-13 |
4 |
B |
$16.00 |
$1,920,000 |
D/D |
120,000 |
2,013,102 |
2.45 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2008-08-21 |
4 |
S |
$35.63 |
$4,274,131 |
I/I |
(119,563) |
9,713,039 |
0 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2011-05-12 |
4 |
S |
$87.43 |
$8,742,630 |
I/I |
(100,000) |
5,421,224 |
0 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2008-09-03 |
4 |
S |
$34.90 |
$3,335,583 |
I/I |
(95,545) |
8,979,904 |
0 |
- |
|
| PRGO |
Perrigo Co |
Vice Chairman |
• • • |
2008-02-19 |
4 |
S |
$35.20 |
$3,350,980 |
I/I |
(94,767) |
9,927,325 |
0 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2011-02-17 |
4 |
S |
$75.16 |
$6,653,991 |
D/D |
(87,651) |
1,130 |
0 |
- |
|
| PRGO |
Perrigo Co |
Director |
– • – |
2008-08-21 |
4 |
S |
$35.88 |
$3,137,056 |
I/I |
(87,264) |
9,625,775 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
